ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 31717 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 31717; 2) Community: the network communities that were significantly associated with the response to NSC 31717; 3) Molecule: the relationships between components within communities and NSC 31717; 4) MDR: the compounds that were significantly associated with the NSC 31717.

NSC Compound Enrichment Correlation
NSC 623436 TGF.alpha.-PE40 0.026296153644827 0.12520377
NSC 623639 Cyclopentane-1,3-dimethanamine, N,N,N,N',N',N'-hexamethyl-2-oxo-, iodide 0.026296153644827 -0.16067682
NSC 625496 Null 0.026296153644827 -0.23444543
NSC 630608 Null 0.026296153644827 -0.1395457
NSC 631542 Null 0.026296153644827 -0.1456053
NSC 634035 4-amino-3-iodo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazin-7-one 0.026296153644827 0.0090056947
NSC 635922 Null 0.026296153644827 0.018931704
NSC 637828 Spiro[5H-dibenzo[a,d]cycloheptene-5,2'(3'H)-furan]-5'-one, 4',5'-dihydro-4'-methylene- 0.026296153644827 -0.1311357
NSC 638634 4-Piperidinone, 3,5-bis(phenylmethylene)-1-(1-oxo-3-phenyl- 2-propenyl)- 0.026296153644827 -0.099833033
NSC 638748 Tetrakis(8-chinolineolato)titanium(IV)-tetrahydrochloride 0.026296153644827 -0.21570744
Total:119  Current:59    [First] [Prev] [Next] [Last]